Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1773 Uterine Cervical Neoplasms 1499 Endometrial Neoplasms 833 Breast Neoplasms 434 Carcinoma, Ovarian Epithelial 405 Fallopian Tube Neoplasms 399 Uterine Cervical Dysplasia 276 Neoplasms 252 Colorectal Neoplasms 179 Uterine Neoplasms 173 Peritoneal Neoplasms 170 Vulvar Neoplasms 155 Lung Neoplasms 150 Pancreatic Neoplasms 141 Prostatic Neoplasms 135 Recurrence 128 Stomach Neoplasms 126 Colonic Neoplasms 116 Papillomavirus Infections 115 Melanoma 101 Sarcoma 97 Urinary Bladder Neoplasms 95 Vaginal Neoplasms 93 Carcinoma, Non-Small-Cell Lung 92 Head and Neck Neoplasms 91 Neoplasm Metastasis 83 Esophageal Neoplasms 82 Testicular Neoplasms 80 Rectal Neoplasms 71 Kidney Neoplasms 62

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Relapsed Ovarian Cancers Patients × Gynecologic × Clear all

NCT04152941 2023-09-06

RETROLA

ARCAGY/ GINECO GROUP

Relapsed Ovarian Cancers Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡